Health Research Sciences introduces a new approach for testing macular function with the purpose of early detection of Age-Related Macular Degeneration (AMD), Diabetic Maculopathy and other retinal pathologies. The MDD-2 Macular Degeneration Detection Device has a unique, hand-held design that measures photostress recovery and solves the problem of inconsistent macular function testing.
Current screening processes that detect the possibility and probability of macular disease are performed with a wide variety of instruments and equipment and can be interpreted in many different ways . These devices were not designed for retinal health monitoring with proven sensitivity, specificity, reproducibility and accuracy.
The MDD-2 enables Primary Care Physicians, Optometrists, Ophthalmologists and Endocrinologist to easily and efficiently measure macular function for the purpose of early detection of AMD, Diabetic Retinopathy and other central retinal diseases. The test may be administered by a trained technician/assistant and takes approximately 5 minutes to complete. Results are available immediately and easily interpreted by the physician.
The MDD-2 provides reproducible measurements of macular function (precise photostress recovery times) which are documented in a concise format for health professional interpretation. The MDD-2 also permits monitoring of central retinal health over time and can warn of deterioration in function at an early stage.
Most healthcare providers and vision scientists agree that early detection of CNV (from AMD) could be one of the most important factors contributing to the reduction of blindness over the next several years. |
